Review Article Integrin signaling aberrations in prostate cancer
Hira Lal Goel, Naved Alam, Isaac N.S. Johnson & Lucia R. Languino
Department of Cancer Biology, Prostate Cancer Discovery and Development Program, Cancer Center, University of Massachusetts Medical School, Worcester, MA 01605
Received April 18, 2009; accepted April 20, 2009; available online April 25, 2009
Abstract: Integrins are cell surface receptors for extracellular matrix proteins and play a key role in cell survival, proliferation, migration and gene expression. Integrin signaling has been shown to be deregulated in several types of cancer, including prostate cancer. This review is focused on integrin signaling pathways known to be deregulated in prostate cancer and to promote prostate cancer progression. (AJTR904003).
Address all correspondence to: Lucia R. Languino, PhD Department of Cancer Biology Prostate Cancer Discovery and Development Program, Cancer Center, University of Massachusetts Medical School, Worcester, MA 01605 Email: lucia.languino@umassmed.edu